What Is Ebola
What is Ebola?
1. Simply, the Ebola virus is an aggressive pathogen that causes a highly lethal fever syndrome in humans and nonhuman primates.
Ebola was discovered in 1976, originally. Five Ebola species have been identified as time has progressed.
Ebola was named for a small river near Maridi, Sudan. Since the emergence of filo viruses in 1967, there have been over 1000 cases of Ebola or Marburg, with more than 50% of the patients dying within days on the onset of acute symptoms. It is considered dangerous, as there has been no known vaccine.
2.
How would I tell if I contracted the Ebola virus? The incubation period is 2 to 21 days. Humans are not infectious until they develop symptoms. First symptoms are the sudden onset of fever fatigue, muscle pain, headache and sore throat. This is followed by vomiting, diarrhea, rash, symptoms of impaired kidney and liver function, and in some cases, both internal and external. You would need to have physical contact with the infected or their bodily fluids when they are sick in order to contract the virus.
Life after Ebola
If you, unfortunately, contract Ebola, and luckily survive, then your worries are over. Studies of blood samples taken from Ebola survivors a few years after they became infected with the virus show that these people have “developed antibodies that can neutralize the Ebola virus,” according to Dr. Bruce Ribner, director of the infectious disease unit at Emory University Hospital in Atlanta.
Current Treatment
ZMapp, being developed by Mapp Biopharmaceutical Inc., is an experimental treatment, for use with individuals infected with Ebola virus. It has not yet been tested in humans for safety or effectiveness. No FDA-approved vaccine or medicine is available for Ebola. Symptoms of Ebola are treated as they appear. The following basic interventions can significantly improve the chances of survival:
Providing (IV)and balancing electrolytes (body salts)
Maintaining oxygen
1. Simply, the Ebola virus is an aggressive pathogen that causes a highly lethal fever syndrome in humans and nonhuman primates.
Ebola was discovered in 1976, originally. Five Ebola species have been identified as time has progressed.
Ebola was named for a small river near Maridi, Sudan. Since the emergence of filo viruses in 1967, there have been over 1000 cases of Ebola or Marburg, with more than 50% of the patients dying within days on the onset of acute symptoms. It is considered dangerous, as there has been no known vaccine.
2.
How would I tell if I contracted the Ebola virus? The incubation period is 2 to 21 days. Humans are not infectious until they develop symptoms. First symptoms are the sudden onset of fever fatigue, muscle pain, headache and sore throat. This is followed by vomiting, diarrhea, rash, symptoms of impaired kidney and liver function, and in some cases, both internal and external. You would need to have physical contact with the infected or their bodily fluids when they are sick in order to contract the virus.
Life after Ebola
If you, unfortunately, contract Ebola, and luckily survive, then your worries are over. Studies of blood samples taken from Ebola survivors a few years after they became infected with the virus show that these people have “developed antibodies that can neutralize the Ebola virus,” according to Dr. Bruce Ribner, director of the infectious disease unit at Emory University Hospital in Atlanta.
Current Treatment
ZMapp, being developed by Mapp Biopharmaceutical Inc., is an experimental treatment, for use with individuals infected with Ebola virus. It has not yet been tested in humans for safety or effectiveness. No FDA-approved vaccine or medicine is available for Ebola. Symptoms of Ebola are treated as they appear. The following basic interventions can significantly improve the chances of survival:
Providing (IV)and balancing electrolytes (body salts)
Maintaining oxygen
Bibliography: http://www.bloomberg.com/politics/articles/2014-10-29/polls-show-the-ebola-panic-starting-to-fade http://www.cdc.gov/vhf/ebola/treatment/ http://www.tarakharper.com/v_ebola.htm